Wilmington, Delaware, United States, 2024-Mar-26 — /EPR Network/ — Alpha-1 antitrypsin deficiency (AATD) is a hereditary condition characterized by low levels of alpha-1 antitrypsin (AAT) [read full press release…]
ALBANY, US, 2019-May-17 — /EPR Network/ —Looking at the current market trends as well as the promising demand status of the “Alpha 1 Antitrypsin Deficiency [read full press release…]
Albany NY, USA, 2018-Apr-10 — /EPR Network/ —Alpha-1 Antitrypsin also referred as AAT, is a type of protein belongs to the class protease inhibitor. This [read full press release…]
Albany NY, USA, 2017-Oct-03 — /EPR Network/ —A fresh report titled “Global Alpha 1 Antitrypsin Deficiency Treatment Market Estimated to Reach a Valuation of $2,908.1 [read full press release…]
